Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
3.980
-0.020 (-0.50%)
At close: Apr 22, 2026, 4:00 PM EDT
4.060
+0.080 (2.01%)
After-hours: Apr 22, 2026, 6:26 PM EDT
Cellectis Market Cap
Cellectis has a market cap or net worth of $283.29 million as of April 22, 2026. Its market cap has increased by 241.72% in one year.
Market Cap
283.29M
Enterprise Value
163.82M
1-Year Change
241.72%
Ranking
Category
Stock Price
$3.98
Market Cap Chart
Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $283.29M, a decrease of -78.92%. That is a compound annual growth rate of -13.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 289.40M | -17.34% |
| Dec 31, 2025 | 350.10M | 169.72% |
| Dec 31, 2024 | 129.80M | -24.18% |
| Dec 29, 2023 | 171.20M | 78.89% |
| Dec 30, 2022 | 95.70M | -74.09% |
| Dec 31, 2021 | 369.30M | -67.88% |
| Dec 31, 2020 | 1.15B | 58.27% |
| Dec 31, 2019 | 726.40M | 2.87% |
| Dec 31, 2018 | 706.10M | -31.45% |
| Dec 29, 2017 | 1.03B | 72.73% |
| Dec 30, 2016 | 596.30M | -43.80% |
| Dec 31, 2015 | 1.06B | -21.04% |
| Mar 25, 2015 | 1.34B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Editas Medicine | 340.59M |
| Anavex Life Sciences | 338.25M |
| NervGen Pharma | 331.82M |
| Artiva Biotherapeutics | 315.38M |
| Foghorn Therapeutics | 315.22M |
| Abeona Therapeutics | 311.49M |
| LENZ Therapeutics | 307.74M |
| NovaBridge Biosciences | 307.63M |